Mostrando resultados 781 - 790 de 56557.
Search results
CSIC has developed a risk score method based on six novel biomarkers for determining the prognosis of patients at early stage of colorectal cancer (…
CSIC, through the Institute of Materials Science of Barcelona ICMAB have developed a new YBCO precursor solution suitable for TLAG-CSD growth of…
CSIC has developed a vaccine candidate based on a modified Vaccinia virus Ankara (MVA) vector, that contains a codon-optimized gene sequence encoding…
CSIC and the University of Seville have developed a method and device for generating true random numbers from Static Random Access Memory (SRAM)…
CSIC has developed an efficient DNA SARS-CoV-2 vaccine prototype based on the combined administration of the spike (S) glycoprotein as well as the…
CSIC discloses peptides for use in the treatment of retinitis pigmentosa. This invention belongs to the field of vision health.
Industrial partners…
CSIC has developed, using genetic engineering techniques, RNA replicons from the virus causing Middle East Respiratory Syndrome (MERS-CoV),…
CSIC, in collaboration with the Andalusian Health System, has developed nanoparticles that, comprising a core consisting of DyPO4 or NaDy(MoO4)2, and…
CSIC, CICbioGUNE and Ghent University have developed a new phloretin derivative, in particular an acyl-alpha-glucoside, which shows enhanced skin…
The CSIC, through the INIA-CSIC in collaboration with the University of Alcalá, University of Almería and University of Córdoba has developed a…